Found: 12
Select item for more details and to access through your institution.
Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036402
- By:
- Publication type:
- Article
Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005717
- By:
- Publication type:
- Article
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
- Published in:
- Nature, 2010, v. 464, n. 7287, p. 431, doi. 10.1038/nature08833
- By:
- Publication type:
- Article
Mediation of TNF receptor-associated factor effector functions by apoptosis signal-regulating kinase-1 (ASK1).
- Published in:
- Oncogene, 1999, v. 18, n. 42, p. 5814, doi. 10.1038/sj.onc.1202975
- By:
- Publication type:
- Article
Bcl-2 targeted to the endoplasmic reticulum can inhibit apoptosis induced by Myc but not etoposide in Rat-1 fibroblasts.
- Published in:
- Oncogene, 1999, v. 18, n. 23, p. 3520, doi. 10.1038/sj.onc.1202716
- By:
- Publication type:
- Article
Targeting cancer with kinase inhibitors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Requirement for glycogen synthase kinase-3beta in cell survival and NF-KB activation.
- Published in:
- Nature, 2000, v. 406, n. 6791, p. 86, doi. 10.1038/35017574
- By:
- Publication type:
- Article
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents.
- Published in:
- Journal of Cell Biology, 2008, v. 183, n. 1, p. 101, doi. 10.1083/jcb.200801099
- By:
- Publication type:
- Article
Erratum: Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.
- Published in:
- Nature, 2013, v. 502, n. 7470, p. 258, doi. 10.1038/nature12659
- By:
- Publication type:
- Article
Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers.
- Published in:
- Nature, 2013, v. 501, n. 7466, p. 232, doi. 10.1038/nature12441
- By:
- Publication type:
- Article
pHUSH: a single vector system for conditional gene expression.
- Published in:
- BMC Biotechnology, 2007, v. 7, p. 1, doi. 10.1186/1472-6750-7-61
- By:
- Publication type:
- Article
P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 9, p. 606, doi. 10.1093/jnci/djt054
- By:
- Publication type:
- Article